MIT researchers discovered a way to treat Fragile X syndrome by targeting NMDA receptors, restoring synaptic balance and ...
MIT neuroscientists have made a breakthrough in treating fragile X syndrome by leveraging a novel neurotransmitter signaling ...
Objective: To determine the efficacy and tolerability of magnesium valproate as monotherapy in patients with partial or generalised epilepsy. Design and Setting: This was a nonblinded study ...
MIT researchers suggests a potential molecular strategy for treating fragile X syndrome by enhancing NMDA subunit function.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback